Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Advanced patent-based synthesis of 4-Methylsulfonyltoluene offers high purity and cost efficiency for pharmaceutical intermediate supply chains globally.
Patent CN102336710B reveals efficient synthesis route. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.
Patent CN109988161A details a telescoped synthesis for Empagliflozin, offering significant cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Patent CN104744437A details a simplified rabeprazole preparation method offering significant supply chain stability and cost reduction in API manufacturing for global partners.
Patent CN101863854A details a cost-effective synthesis of 2-(3-cyano-4-isobutoxy)phenyl-4-methyl-5-thiazolecarboxylic acid using bromination, offering high purity and scalability.
Novel Topiroxostat preparation using Potassium Ferrocyanide. High purity >99%, safe industrial scale-up, cost-effective API intermediate manufacturing.
Novel method for azithromycin impurity synthesis ensures high purity. Reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN114836486B details a novel monooxygenase method for synthesizing chiral beta-amino alcohols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN102465159B details a green microbial route for Eslicarbazepine. Enhance supply chain reliability and reduce manufacturing costs with this scalable biocatalytic technology.
Patent CN102465159B enables green microbial synthesis. Reduces cost and improves supply chain reliability for epilepsy drug intermediates significantly.
Patent CN103193608A details a high-yield veratraldehyde synthesis route offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN101883761B reveals a novel Moguisteine synthesis route using stable cyclic intermediates, offering significant cost reduction and high-purity pharmaceutical manufacturing advantages.
Optimized GCLE synthesis using NCS chlorination enhances safety and yield. A reliable solution for cephalosporin manufacturing supply chains.
Patent CN109836341A reveals a safer salicylamine acetate method. Achieve cost reduction in pharma manufacturing with high-purity pharmaceutical intermediates.
Patent CN1473164A details a novel transketalization route for steroid intermediates, offering superior stereoselectivity and cost-effective manufacturing for global pharmaceutical supply chains.
Patent CN106317154A details a safe 4-step route for 17α-hydroxyprogesterone. Eliminate toxic reagents and achieve high yields for reliable pharmaceutical intermediate supply.
Patent CN107840866A reveals novel phosphine treatment for palladium removal in Abiraterone acetate synthesis ensuring high purity and supply chain reliability for pharmaceutical manufacturers.
Novel nickel-catalyzed method enhances yield and purity for flurbiprofen intermediates. Reduces manufacturing costs and ensures supply chain stability for global pharmaceutical partners.
Patent CN104370905B details a high-yield ABT-199 synthesis route. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN101407469A details a greener chlorination route for Bupropion HCl, replacing bromine to lower costs and environmental impact for pharmaceutical manufacturing.